Corticosteroid use linked to worse outcomes for patients with lyme disease-associated facial paralysis

Patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone, new research shows. Based on these findings, the researchers urge caution in prescribing corticosteroids to patients with acute Lyme disease-associated facial paralysis.